Leerink Partners Remains Bullish on Evolent Health (EVH) Following Investor Call
Tweet Send to a Friend
Leerink Partners reiterated an Outperform rating and $20.00 price target on Evolent Health (NYSE: EVH) following the company's call with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
